Operative Management of Early GAllbladder cancer (OMEGA) study
Not Applicable
- Conditions
- Health Condition 1: K828- Other specified diseases of gallbladder
- Registration Number
- CTRI/2021/07/034524
- Lead Sponsor
- ANITA BALAKRISHNA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Retrospective arm: All patients with gallbladder cancer at any T and N stage, who underwent resection between January 2010 and January 2020
Prospective arm: All patients undergoing surgery for gallbladder cancer for any T and N stage from June 2022 to June 2025 can be included in this study
Exclusion Criteria
Patients with gallbladder cancer who are not candidates for surgery, e.g. due to metastatic disease or ill health, will be excluded from the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method As this is a qualitative /descriptive study, there are no primary end point however the primary objective is to assess the effect of extent of surgical resection and lymphadenectomy on overall survival and disease-free survival from gallbladder cancer at all stages of resectable diseaseTimepoint: baseline
- Secondary Outcome Measures
Name Time Method Identify risk factors predicting requirement for radical or extended resections compared to simple cholecystectomyTimepoint: base line